Hemophilia Drug Development

Conference themes
Given the excitement and anticipation of increasingly more promising prophylactic treatments and gene therapy, the inaugural Hemophilia Drug Development Summit plays host to the leading pharma and biotech players working to develop longer acting and more efficacious therapies to overcome significant unmet medical need and prevent resistance to factor replacement therapies.

Professional congress organizer (PCO)
Hanson Wade

Notes
URLs:

Booking: https://go.evvnt.com/223758-3?pid=4832

Brochure: https://go.evvnt.com/223758-4?pid=4832

Speakers: Daniel Leonard, Director of Global Patient Advocacy, UniQure, Craig Benson, Clinical Research Director

https://go.evvnt.com/223758-1?pid=4832

Mr. Charlotte Harrison